Plasma Metabolome Signature Indicative of
BRCA1 germline mutation
HIF1 alpha
NAD+ balance
aerobic glycolysis
breast cancer
energy metabolism
lactate
plasma metabolome
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
11
2020
accepted:
19
01
2021
entrez:
26
4
2021
pubmed:
27
4
2021
medline:
27
4
2021
Statut:
epublish
Résumé
Individuals carrying a pathogenic germline variant in the breast cancer predisposition gene
Identifiants
pubmed: 33898308
doi: 10.3389/fonc.2021.627217
pmc: PMC8058469
doi:
Types de publication
Journal Article
Langues
eng
Pagination
627217Informations de copyright
Copyright © 2021 Penkert, Märtens, Seifert, Auber, Derlin, Hille-Betz, Hörmann, Klopp, Prokein, Schlicker, Wacker, Wallaschek, Schlegelberger, Hiller, Ripperger and Illig.
Déclaration de conflit d'intérêts
MS was employed by the company Connexome Consulting. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Immunity. 2014 Oct 16;41(4):518-28
pubmed: 25367569
Nat Rev Cancer. 2015 Jul;15(7):440-8
pubmed: 26084394
Oncotarget. 2017 Jan 17;8(3):3811-3825
pubmed: 28002811
PLoS One. 2014 Jul 10;9(7):e102438
pubmed: 25010005
Breast Cancer Res Treat. 2008 Oct;111(3):475-80
pubmed: 18030615
PLoS One. 2013;8(2):e56055
pubmed: 23409121
Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):84-94
pubmed: 28167050
Oncotarget. 2019 Mar 29;10(25):2475-2483
pubmed: 31069010
Mol Cell. 2008 Oct 10;32(1):11-20
pubmed: 18851829
Oncotarget. 2016 Aug 16;7(33):52974-52992
pubmed: 27259235
Cell. 2013 Dec 19;155(7):1624-38
pubmed: 24360282
Sci Rep. 2017 Dec 19;7(1):17831
pubmed: 29259228
Nat Med. 2016 Aug;22(8):933-9
pubmed: 27322743
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Nat Metab. 2020 Jul;2(7):566-571
pubmed: 32694798
Int J Mol Sci. 2019 Jan 09;20(2):
pubmed: 30634433
Cell Res. 2010 Nov;20(11):1201-15
pubmed: 20820192
Anal Chem. 2009 May 1;81(9):3429-39
pubmed: 19358599
Cell. 2000 Jul 21;102(2):257-65
pubmed: 10943845
Mol Cancer Res. 2018 Mar;16(3):439-452
pubmed: 29330289
Oncotarget. 2016 Oct 11;7(41):67626-67649
pubmed: 27590516
Sci Rep. 2019 Jul 4;9(1):9702
pubmed: 31273285
Am J Hum Genet. 2019 Oct 3;105(4):813-821
pubmed: 31564436
Biochem J. 2008 Jun 15;412(3):477-84
pubmed: 18393939
Bioinformatics. 2004 Oct 12;20(15):2479-81
pubmed: 15073010
Cell Cycle. 2012 Nov 15;11(22):4167-73
pubmed: 23047605
Cell Cycle. 2012 Dec 1;11(23):4402-13
pubmed: 23172369
J Lipid Res. 2014 Apr;55(4):668-80
pubmed: 24565757
Nat Struct Mol Biol. 2010 Dec;17(12):1406-13
pubmed: 21102443
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1680-5
pubmed: 18230721
Breast Cancer Res. 2014 Aug 05;16(4):415
pubmed: 25091696
Cancer Prev Res (Phila). 2017 Apr;10(4):255-266
pubmed: 28264838
Cancer Res. 2017 Feb 1;77(3):595-600
pubmed: 28104682
EBioMedicine. 2015 Sep 09;2(10):1331-9
pubmed: 26629528
Cell Cycle. 2014;13(16):2564-71
pubmed: 25486197
Oncogene. 2006 Sep 25;25(43):5854-63
pubmed: 16998500
Lancet Oncol. 2013 Nov;14(12):1226-32
pubmed: 24140203
Cell Metab. 2006 Mar;3(3):177-85
pubmed: 16517405
Trends Cell Biol. 2018 Mar;28(3):213-223
pubmed: 29241686
Proteomes. 2018 Mar 27;6(2):
pubmed: 29584711